[Treatment of chronic hepatitis C].
Bell
Helge
H
Seksjon for leversykdommer Medisinsk klinikk Aker universitetssykehus 0514 Oslo. helge.bell@ioks.uio.no
Dalgard
Olav
O
Bjøro
Kristian
K
Hellum
Kjell Block
KB
Myrvang
Bjørn
B
D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000075202:Contraindications; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use*; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use*
D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin